Back

Uric acid variability is associated with poor prognosis in heart failure

10 May 2026 (11:30 - 12:00)
Organised by: Logo
Congress Presentation Part of: Systemic inflammation, metabolic risk, and data-driven prognostication in heart failure Biomarkers HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Viana Copeland

Chaim Sheba Medical Center, Tel Aviv Universty, Ramat Gan (Israel)

4 More presentations in this session

Presentation thumbnail
The role of HALP and modified HALP scores in predicting in-hospital mortality in patients with low ejection fraction heart failure presenting with acute decompensation
Doctor A. Akgun (Ankara, TR)
Abstract Slides
Presentation thumbnail
Determinants of C-reactive protein levels in general population, subject at cardiovascular risk and heart failure
Doctor L. Monzo (Vandoeuvre-Les-Nancy, FR)
Abstract Slides
Presentation thumbnail
Prognostic significance of c-reactive protein in heart failure: a report from a global federated research network
Doctor M. Busti (Nancy, FR)
Abstract Slides
Presentation thumbnail
Associations between combined systemic inflammation and central obesity with heart failure in US adults
Mr Y. Raza (Norwich, GB)
Abstract Slides

Access the full session

Session thumbnail
Systemic inflammation, metabolic risk, and data-driven prognostication in heart failure

The Event

Event poster

Heart Failure 2026

10 May 2026 11:30 CET
You may be interested in
thumbnail
Congress Session
From genetic signatures to clinical implications
thumbnail
Congress Presentation
A proteo-genomic discovery approach to identify markers of early heart failure
thumbnail
Congress Presentation
State-of-the-art lecture on current state of the diagnosis of heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources